1Hug H. Fas-mediated apoptosis intumor and defense. Biol Chem,1997,378(12): 1405
2Ohmori T, Podack ER, Nishio K, et al. Apoptosis of lung cancer cells caused by someanti-cancer agents (MMC, CPT-11, and ADM) is inhibited by Bcl-2. Biochem Bioph Res Commun,1993,1921 (1): 30
3Oltavai ZN,Millimen CL,Korsmeyer SJ,et al. Bcl-2 heterodimerizes in vivo withconserved homolog, Bax, that accelerates programmed cell death. Cell, 1993,74 (4): 609
4Boise LH, Gonzalez-Garcia M, Postema CE, et al. Bcl-x, a Bcl-2 related gene thatfunctions as dominant regulator of apoptotic cell death. Cell, 1993,74 (3): 597
5Yang E,Zha JP,Jockel J ,et al. Bad,a heterodimeric partner for BclXL and Bcl-2,displaces Bax and promotes cell death. Cell, 1995,80 (2):285
6Takayama S, Sato T, Krajewski S, et al. Cloning and functional analysis of BAG-1: anovel Bcl-2 binding protein with anti-cell death activity. Cell, 1995,80 (2): 279
7Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Bid, 1993,75(2):241
10Vescio R,Berenson J. Lichtenstein aupregulated expression of Bcl-2inmutiplemyltiple myeloma cells induced by exposure to doxorubicin etoposideand hydrogenperoxide. Blood, 1996,88(5): 1805
8Hwang YY, Moon H , Cho SH , et al. Ten-year survival of patients with locally advanced stage Ⅰb2 and Ⅱb cervical cancer after neoadjuvant chemotherapy and radical hysterectomy [ J] . Gynecol Oncol , 2001 , 82 (4) :402-408.
9Huang HJ , Chang TC , Hong JH , et al . Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky ( ≥ 4 cm) stage Ⅰb and Ⅱa cervical carcinoma[J]. Int J Gynecol'Cancer , 2003 , 13 : 204-211.
10Bolis G, van Zainten PI, Scarfone G, et al. Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage Ⅰb - Ⅱa invasive cervical cancer[ J] . Gynecol Oncol , 1996 , 63 : 62-65.
